Application(s)
|
Anthelmintic
|
Application(s)
|
Investigated for treatment of chronic stronglyoidiasis, and for microsporidiosis in AIDS patients
|
Mechanism of Action
|
Causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin,
|
Mechanism of Action
|
thus inhibiting its polymerization or assembly into microtubules.
|
Mechanism of Action
|
The loss of the cytoplasmic microtubules leads to impaired uptake of glucose by the larval and adult stages of the susceptible parasites, and depletes their glycogen stores.
|
Mechanism of Action
|
Degenerative changes in the endoplasmic reticulum, the mitochondria of the germinal layer, and the subsequent release of lysosomes result in decreased production of adenosine triphosphate (ATP),
|
Mechanism of Action
|
which is the energy required for the survival of the helminth.
|
Mechanism of Action
|
Due to diminished energy production, the parasite is immobilized and eventually dies.
|
Mechanism of Action
|
Also has been shown to inhibit the enzyme fumarate reductase, which is helminth-specific.
|
Mechanism of Action
|
This action may be considered secondary to the effect
|